Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Abbott Labs (ABT)
NYSE:ABT
Abbott Labs (ABT) Stock Price & Analysis
7,122 Followers
ABT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$88.80 - $121.04
Previous Close$107.59
Volume3.85M
Average Volume (3M)5.87M
Market Cap
$186.69B
Enterprise Value$194.31B
Total Cash (Recent Filing)$7.28B
Total Debt (Recent Filing)$14.68B
Price to Earnings (P/E)33.5
Beta0.70
Next Earnings
Jul 18, 2024EPS Estimate
$1.11Last Dividend Ex-Date
Apr 12, 2024Dividend Yield1.93%
Share Statistics
EPS (TTM)3.21
Shares Outstanding1,735,184,289
10 Day Avg. Volume6,320,314
30 Day Avg. Volume5,874,623
Standard Deviation0.06
R-Squared0.41
Alpha0.00038
Financial Highlights & Ratios
Price to Book (P/B)30.58
Price to Sales (P/S)4.63
Price to Cash Flow (P/CF)15.30
P/FCF Ratio19.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.84
Enterprise Value/Gross Profit8.78
Enterprise Value/Ebitda18.43
Forecast
1Y Price Target
$128.83Price Target Upside19.74% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
Abbott Labs News
Bulls Say, Bears Say
Bulls Say
Financial GuidanceManagement raised organic revenue guidance early in the year, a move not seen since 2016, signaling strong future performance.
Market PerformanceElectrophysiology growth remains strong, indicating a healthy market and expanding global procedure volumes, which may lead to increased investor confidence.
Product LaunchThe launch of several new products by ABT is likely to enhance the company's growth, showcasing innovation and market expansion.
Bears Say
Litigation RiskThe company is named as a defendant in a significant number of federal and state NEC cases, which could potentially lead to substantial damages.
Market CompetitionCompetition in the US market has led to a slight decline in the company's device segment, reflecting the challenges it faces in maintaining market share.
Product Approval UncertaintyThe details in the FDA briefing documents for the adcom reviewing the risk/benefits of Abbott's TriClip have generated incremental uncertainty on the panel outcome.
---
Ownership Overview
2.80% Insiders
26.14% Mutual Funds
20.09% Other Institutional Investors
50.98% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ABT FAQ
What was Abbott Labs’s price range in the past 12 months?
Abbott Labs lowest stock price was $88.80 and its highest was $121.04 in the past 12 months.
What is Abbott Labs’s market cap?
Currently, no data Available
When is Abbott Labs’s upcoming earnings report date?
Abbott Labs’s upcoming earnings report date is Jul 18, 2024 which is in 85 days.
How were Abbott Labs’s earnings last quarter?
Abbott Labs released its earnings results on Apr 17, 2024. The company reported $0.98 earnings per share for the quarter, beating the consensus estimate of $0.955 by $0.025.
Is Abbott Labs overvalued?
According to Wall Street analysts Abbott Labs’s price is currently Undervalued.
Does Abbott Labs pay dividends?
Abbott Labs pays a Quarterly dividend of $0.55 which represents an annual dividend yield of 1.93%. See more information on Abbott Labs dividends here
What is Abbott Labs’s EPS estimate?
Abbott Labs’s EPS estimate is $1.11.
How many shares outstanding does Abbott Labs have?
Abbott Labs has 1,735,184,300 shares outstanding.
What happened to Abbott Labs’s price movement after its last earnings report?
Abbott Labs reported an EPS of $0.98 in its last earnings report, beating expectations of $0.955. Following the earnings report the stock price went down -3.031%.
Which hedge fund is a major shareholder of Abbott Labs?
Among the largest hedge funds holding Abbott Labs’s share is Fisher Asset Management LLC. It holds Abbott Labs’s shares valued at 1B.
---
Abbott Labs Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$128.83 (19.74% Upside)
$128.83 (19.74% Upside)
Blogger Sentiment
Bullish
ABT Sentiment 87%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 164.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $8.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 2.1%
Last 30 Days ▼ 1.0%
Last 30 Days ▼ 1.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Company Description
Abbott Labs
Abbott Laboratories offers a diversified line of healthcare products. It operates through four reportable segments: Established Pharmaceutical Products International (includes international sales of branded generic pharmaceutical products), Nutritional Products Diagnostic Products and Medical Devices. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
---
ABT Company Deck
---
ABT Earnings Call
Q1 2024
0:00 / 0:00
---
ABT Net sales Breakdown
42.10% Medical Devices
24.90% Diagnostic Products
20.33% Nutritional Products
12.63% Established Pharmaceutical Products
0.03% Other
---
ABT Stock 12 Months Forecast
Average Price Target
$128.83
▲(19.74% Upside)
Technical Analysis
Best Analysts Covering ABT
1 Year
1 Year Success Rate
40/47 ratings generated profit
1 Year Average Return
+18.77%
reiterated a buy rating 7 days ago
Copying Jayson Bedford's trades and holding each position for 1 Year would result in 85.11% of your transactions generating a profit, with an average return of +18.77% per trade.
---